Health ❯ Healthcare ❯ Medical Research

Clinical Trials

Cancer Treatment Alzheimer's Disease Immunotherapy Innovative Treatments Gene Therapy Breast Cancer Patient Outcomes Cancer Vaccines Transplantation Studies Stem Cell Therapy Innovative Therapies Oncology Drug Development Duchenne Muscular Dystrophy Prostate Cancer Transplantation Research Hypertension Colorectal Cancer Cancer Immunotherapy Multiple Sclerosis Cancer Treatments Drug Efficacy Bladder Cancer Pediatric Studies Gene Editing Spinal Cord Injury Breast Cancer Treatment Obesity Treatment Cancer Research Type 1 Diabetes Surgical Techniques Spinal Cord Injury Treatment Experimental Drugs Biomarkers Parkinson's Disease Cancer Therapy Lung Cancer Pancreatic Cancer AI in Medicine Dementia Multiple Myeloma Vaccine Development Radiation Therapy Blood Tests Adaptive Deep Brain Stimulation Study Findings Observational Studies New Treatments AI Applications in Medicine Efficacy Studies Precision Medicine Organ Transplants Translational Medicine Randomized Controlled Trials Innovative Surgical Techniques Polilaminina Xenotransplantation Studies IgA Nephropathy FDA Approval Alzheimer's Disease Treatments Alzheimer's Treatments Phase 3 Trials Experimental Therapies Asthma Treatment Radiopharmaceuticals Guideline Development Oncolytic Virus Therapy Ethics in Research Neurosurgery AI Performance Evaluation Pediatric Medicine Gene Therapy Trials Diabetes Treatment Phase II Studies Muscular Dystrophy Evidence-Based Medicine Xenotransplantation Research Case Studies Chronic Obstructive Pulmonary Disease Ophthalmology Tirzepatide Heart Revival Techniques Safety Studies Enteral Ventilation Late-Stage Studies Innovative Testing Methods AI in Clinical Trials Innovative Procedures Stroke Treatment Long-term Effects NHS App Spinal Muscular Atrophy Eli-cel Gene Therapy Cardiovascular Health Benralizumab Eosinophilic Exacerbation Epilepsy Treatment Retinal Diseases FDA Regulations Erythropoietic Protoporphyria

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

The company said it will seek U.S. approval by filing a Biologics License Application for Zenkuda in Q4 to pursue its first commercial product.

FDA Advisory Panel Backs Grail’s Galleri Blood Test but Flags Key Evidence Gaps

Amivantamab Plus Chemotherapy Shows Longest Survival for EGFR Exon 20 Insertion Lung Cancer

B7‑H3 Antibody‑Drug Conjugates Cut Death Risk by Half in Relapsed Small‑Cell Lung Cancer

AstraZeneca's Tozorakimab Cuts COPD Flare‑Ups in Two Phase 3 Trials

Pig Kidney Kept Patient Off Dialysis for 271 Days and Enabled Human Transplant

Scripps Publishes ECG‑CLIP, an AI That Learns From Doctors’ ECG Reports to Boost Heart‑disease Detection

Penn Launches Phase I Trial of ConformalFLASH Proton Therapy

Moderna and Merck Report Phase 3 Success for Personalized mRNA Melanoma Vaccine

UC Irvine Proposes Mitochondrial‑Targeted, Steroid‑Sparing Strategy for CAR T Neurotoxicity

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

VA Launches Nationwide Trial Testing Semaglutide for Alcohol Use Disorder

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

Parents Allege Six‑Year‑Old Died After Paid Gene‑Editing Trial by Shanghai Team

Major Research Centers Launch Nonprofit to Scale Gene‑Editing Treatments

KRAS Vaccine Safely Triggers Lasting Immune Response in People at High Risk for Pancreatic Cancer

DR5–Lig3 Feedback Loop Explains Why MSI Colorectal Tumors Respond to Immunotherapy

Study Finds No Survival Benefit From Continuing Lenalidomide Maintenance Past Two Years

Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal